HLA-DQ3 is a probable risk factor for CMV infection in high-risk kidney transplant patients
BACKGROUND: Cytomegalovirus (CMV) infection in transplant patients with special risk factors remains a major hazard. CMV-seronegative recipients with seropositive donors have the highest risk of developing acute CMV disease. We suggest that the HLA-type may influence the occurrence and the severity of primary CMV infection of these recipients and the measurement of the special HLA-types may be useful in the prediction of acute infection.
METHODS: Since 1999 1213 cadaver kidney transplantations have been performed in our clinic. 163 of 1213 recipients were CMV-seronegative (13%) and 129 of them received the kidney from seropositive donors. All 129 patients received CMV infection prophylaxis. Of 129 CMV-seronegative patients 49 developed acute CMV infection (38%) during the first posttransplant year. CMV infection was diagnosed by CMV antigenemia test and serologic measurements (ELISA). The particular HLA-genotypes of the recipients were studied before the transplantation. The occurrence and the severity of CMV infection was investigated in association with HLA-types.
RESULTS: We found different acute CMV infection distribution in the careers and non-careers of investigated HLA-types: HLA-A2, HLA-B12, HLA-Cw7, HLA-DR6 and HLA-DR11, but the differences were not significant in these HLA-types (P = 0.26, P = 0.37, P = 0.83, P = 0.07 and P = 0.37). While investigating HLA-DQ3, we found that of 68 DQ3-positive patients 32 (47%), of 61 DQ3-negative patients 17 (28%) had acute CMV infection and this difference was found to be significant. This result was confirmed by univariate and multivariate Cox Regression (P = 0.001) and the appropriate significance level was considered by Bonferroni correction.
CONCLUSIONS: HLA-DQ3 was found to be an independent predictor of CMV infection. Our data suggest that patients positive for HLA-DQ3 are more susceptible to CMV infection than a comparable group of patients negative for HLA-DQ3. This result was not due to rejection and/or treatment for rejection and was not influenced by induction therapy. Although we found more symptomatic infections among DQ3+ patients the difference was not significant (P = 0.19). Comparing the gender proportion among all 1213 kidney recipients and among CMV-seronegative recipients we found that the proportion of males is significantly higher among CMV-seronegative recipients (P < 0.001).
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2008 |
---|---|
Erschienen: |
2008 |
Enthalten in: |
Zur Gesamtaufnahme - volume:23 |
---|---|
Enthalten in: |
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association - 23(2008), 8 vom: 05. Aug., Seite 2673-8 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Varga, Marina [VerfasserIn] |
---|
Links: |
---|
Themen: |
---|
Anmerkungen: |
Date Completed 20.02.2009 Date Revised 17.11.2011 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1093/ndt/gfn111 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM178163783 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM178163783 | ||
003 | DE-627 | ||
005 | 20231223151638.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231223s2008 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1093/ndt/gfn111 |2 doi | |
028 | 5 | 2 | |a pubmed24n0594.xml |
035 | |a (DE-627)NLM178163783 | ||
035 | |a (NLM)18332066 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Varga, Marina |e verfasserin |4 aut | |
245 | 1 | 0 | |a HLA-DQ3 is a probable risk factor for CMV infection in high-risk kidney transplant patients |
264 | 1 | |c 2008 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 20.02.2009 | ||
500 | |a Date Revised 17.11.2011 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a BACKGROUND: Cytomegalovirus (CMV) infection in transplant patients with special risk factors remains a major hazard. CMV-seronegative recipients with seropositive donors have the highest risk of developing acute CMV disease. We suggest that the HLA-type may influence the occurrence and the severity of primary CMV infection of these recipients and the measurement of the special HLA-types may be useful in the prediction of acute infection | ||
520 | |a METHODS: Since 1999 1213 cadaver kidney transplantations have been performed in our clinic. 163 of 1213 recipients were CMV-seronegative (13%) and 129 of them received the kidney from seropositive donors. All 129 patients received CMV infection prophylaxis. Of 129 CMV-seronegative patients 49 developed acute CMV infection (38%) during the first posttransplant year. CMV infection was diagnosed by CMV antigenemia test and serologic measurements (ELISA). The particular HLA-genotypes of the recipients were studied before the transplantation. The occurrence and the severity of CMV infection was investigated in association with HLA-types | ||
520 | |a RESULTS: We found different acute CMV infection distribution in the careers and non-careers of investigated HLA-types: HLA-A2, HLA-B12, HLA-Cw7, HLA-DR6 and HLA-DR11, but the differences were not significant in these HLA-types (P = 0.26, P = 0.37, P = 0.83, P = 0.07 and P = 0.37). While investigating HLA-DQ3, we found that of 68 DQ3-positive patients 32 (47%), of 61 DQ3-negative patients 17 (28%) had acute CMV infection and this difference was found to be significant. This result was confirmed by univariate and multivariate Cox Regression (P = 0.001) and the appropriate significance level was considered by Bonferroni correction | ||
520 | |a CONCLUSIONS: HLA-DQ3 was found to be an independent predictor of CMV infection. Our data suggest that patients positive for HLA-DQ3 are more susceptible to CMV infection than a comparable group of patients negative for HLA-DQ3. This result was not due to rejection and/or treatment for rejection and was not influenced by induction therapy. Although we found more symptomatic infections among DQ3+ patients the difference was not significant (P = 0.19). Comparing the gender proportion among all 1213 kidney recipients and among CMV-seronegative recipients we found that the proportion of males is significantly higher among CMV-seronegative recipients (P < 0.001) | ||
650 | 4 | |a Journal Article | |
650 | 7 | |a HLA-DQ Antigens |2 NLM | |
650 | 7 | |a HLA-DQ3 antigen |2 NLM | |
700 | 1 | |a Rajczy, Katalin |e verfasserin |4 aut | |
700 | 1 | |a Telkes, Gábor |e verfasserin |4 aut | |
700 | 1 | |a Hídvégi, Márta |e verfasserin |4 aut | |
700 | 1 | |a Péter, Antal |e verfasserin |4 aut | |
700 | 1 | |a Remport, Adám |e verfasserin |4 aut | |
700 | 1 | |a Korbonits, Márta |e verfasserin |4 aut | |
700 | 1 | |a Fazakas, János |e verfasserin |4 aut | |
700 | 1 | |a Toronyi, Eva |e verfasserin |4 aut | |
700 | 1 | |a Sárváry, Enikõ |e verfasserin |4 aut | |
700 | 1 | |a Kóbori, László |e verfasserin |4 aut | |
700 | 1 | |a Járay, Jenõ |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association |d 1990 |g 23(2008), 8 vom: 05. Aug., Seite 2673-8 |w (DE-627)NLM012639206 |x 1460-2385 |7 nnns |
773 | 1 | 8 | |g volume:23 |g year:2008 |g number:8 |g day:05 |g month:08 |g pages:2673-8 |
856 | 4 | 0 | |u http://dx.doi.org/10.1093/ndt/gfn111 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 23 |j 2008 |e 8 |b 05 |c 08 |h 2673-8 |